Company / Total Assets
Adaptive Biotechnologies Corp Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$512.7M
FY2025
5-year range
$512.7M / $923.3M
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
#136 of 214
Health Care
What the data says
At $513M, Adaptive Biotechnologies Corp's total assets ranks #136 of 214 in the Health Care sector. Total Assets has declined for 5 consecutive years, from $1.1B in FY2020 to $513M in FY2025.
Based on SEC 10-K filings.
$513M in FY2025 with a 5-year CAGR of -14.4%.
Declined from $661M to $513M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Sector benchmark
#136 of 214 in Health CareTop 64% of 214This company $512.7M Sector average $7.5B
▼
-93.1% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's total assets has declined for 5 consecutive years.
- 5-year CAGR of -14.4%, indicating a declining trend.
- In FY2025, total assets decreased 4.9% year-over-year.
- Ranks #136 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $512.7M | -4.9% |
| FY2024 | $539.4M | -18.4% |
| FY2023 | $661.1M | -22.8% |
| FY2022 | $856.6M | -7.2% |
| FY2021 | $923.3M | -17.3% |
| FY2020 | $1.1B | +22.4% |
| FY2019 | $912.3M | +174.2% |
| FY2018 | $332.7M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026